-
公开(公告)号：US10576052B2
公开(公告)日：2020-03-03
申请号：US15775705
申请日：2016-11-10
Applicant: PERSTORP AB
Inventor： Filip Van Immerseel , Karolien Van Driessche , Richard Ducatelle , Conrad Gerard Schwarzer
IPC: A61K31/22 , A23K20/158 , A23K50/70 , A23L33/12 , A61K31/215
Abstract: The present invention refers to a glycerol ester composition comprising glyceryl monovalerate, for use in preventing and/or alleviating bacterial inflammation in a monogastric animal (including human) by inhibiting the adhesion of pathogenic bacteria to the intestinal lumen of said animal. The present invention also refers to a therapeutic method for promoting the renewal and growth of epithelial cells in the small intestine of a monogastric animal (including human), the method comprising the step of distributing a glycerol ester composition comprising glyceryl monovalerate to said animal.
-
公开(公告)号：US09877945B2
公开(公告)日：2018-01-30
申请号：US15281523
申请日：2016-09-30
Applicant: PERSTORP AB
Inventor： Filip Van Immerseel , Richard Sygall , Karolien Van Driessche , Richard Ducatelle , Conrad Gerard Schwarzer
CPC classification number: A61K31/22 , A23K20/158 , A23K50/70 , A23K50/75 , A23V2002/00 , A61K9/0056 , A61K9/167 , A61K9/50 , A61K31/225 , A61K2300/00 , A23V2200/32 , A23V2250/1884
Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of the glycerol ester composition for modulating the gut flora of galloanserans.
-
公开(公告)号：US10420745B2
公开(公告)日：2019-09-24
申请号：US15562105
申请日：2016-03-17
Applicant: PERSTORP AB
Inventor： Filip Van Immerseel , Karolien Van Driessche , Richard Ducatelle , Conrad Gerard Schwarzer
IPC: A61K31/225 , A23K20/158 , A23K20/105 , A23K50/75 , A61K31/22 , A61P31/04 , A61K47/02 , A61K31/122
Abstract: The present invention refers to a glycerol ester composition comprising the reaction product obtained from reacting valeric acid and glycerol at a molar ratio of between 1:0.8 and 1:1.2, for use in reduction and/or inhibition of the growth of gram-positive, pathogenic bacteria. The present invention also refers to said glycerol ester composition for use in prevention and/or alleviation of necrotic enteritis in the gastric tract of galloanserans.
-
-
Search Results
3
records
(took 0.018 seconds)
